2023-07-20 09:39:40 ET
A Connecticut-based %Healthcare company is turning heads on Thursday after it was announced that its subsidiary was selected to join NVIDIA Inception , a program designed to partner with companies revolutionizing industries with advancements in %ArtificialIntelligence (AI) and data sciences, according to the release.
This caused traders to become eager to get their hands on shares of the parent company %BioSigTechnologies (Nasdaq: ) during Thursday’s premarket hours. At the time of writing, traders are bid for shares of at $1.44/share, which is an implied open +10.77% above yesterday’s close of $1.30. It should be an exciting session for this small cap!
BioSig Technologies is an advanced medical technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare’s biggest priorities-saving time, saving costs, and saving lives. The Company’s first product, the PURE EP System, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate.